# Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies

> **NCT06626269** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 700 (estimated)

## Conditions studied

- Advanced Digestive Cancer
- Advanced Gynecologic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample
- **OTHER:** Tumor tissue

## Key facts

- **NCT ID:** NCT06626269
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2030-02
- **Final completion:** 2032-02
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2025-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626269, "Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06626269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*